ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
977Followers
0Topic
0Badge
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 38,355 shares, the number of shares held decreased 0.31% compared to the previous period and now represents 1.96% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 123,849 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 1.66% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 116,046 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 7.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 38,235 shares, the number of shares held decreased 0.31% compared to the previous period and now represents 6.34% of the total position.
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 51,576 shares, the number of shares held increased 0.45% compared to the previous period and now represents 7.15% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 55,048 shares, the number of shares held increased 0.45% compared to the previous period and now represents 1.84% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 812 shares, the number of shares held decreased 3.03% compared to the previous period and now represents 1.02% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 178,906 shares, the number of shares held increased 1.44% compared to the previous period and now represents 1.97% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 49,997 shares, the number of shares held decreased 1.86% compared to the previous period and now represents 3.5% of the total position.
ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 168 shares, the number of shares held increased 0.62% compared to the previous period and now represents 1.03% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 13,546 shares, the number of shares held increased 0.11% compared to the previous period and now represents 2.13% of the total position.
ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 56 shares, the number of shares held increased 0.22% compared to the previous period and now represents 0.89% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 501,350 shares, the number of shares held decreased 3.95% compared to the previous period and now represents 2.05% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 41,361 shares, the number of shares held decreased 1.86% compared to the previous period and now represents 4.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 31,213 shares, the number of shares held decreased 1.4% compared to the previous period and now represents 9.61% of the total position.
ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 28 shares, the number of shares held increased 0.1% compared to the previous period and now represents 0.98% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 31,629 shares, the number of shares held decreased 1.4% compared to the previous period and now represents 4.03% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 85,289 shares, the number of shares held decreased 3.02% compared to the previous period and now represents 3.57% of the total position.
ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 69,629 shares, the number of shares held decreased 3.02% compared to the previous period and now represents 9.7% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 70,557 shares, the number of shares held decreased 3.02% compared to the previous period and now represents 4% of the total position.
Go to Tiger App to see more news